The global antimicrobial susceptibility tester market is expected to be valued at USD 3.7 Billion in 2022, expected to reach USD 6.37 Billion by 2032. A CAGR worth 5.6% is expected for the market during the 2022 to 2032 forecast period.
Mutation in bacteria, viruses, fungi, and other microbes poses a challenge to modern medical technology since mutation in these living creatures reduces the effectiveness of existing medications.
Environmental factors, like global warming, are hastening the spread of fatal and blood-borne infections. To combat such diseases, researchers are working to develop effective medications, antibiotics, and immune boosters. Antimicrobial susceptibility testers are being used in hospitals, laboratories, and other research settings to examine the response of organisms or groups of organisms to antibiotics.
Because of the changing nature of viruses, bacteria, and other disease-spreading organisms, research efforts are ongoing, and as a result, the demand for antimicrobial susceptibility testing has increased in recent years. Manufacturers of antimicrobial susceptibility testers are always improving their goods in order to provide the most trustworthy products to its end users.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | USD 3.5 Billion |
| Expected Market Value (2022) | USD 3.7 Billion |
| Projected Forecast Value (2032) | USD 6.37 Billion |
| Anticipated Growth Rate (2022 to 2032) | 5.6% |
One of the primary drivers driving the antimicrobial susceptibility tester industry is the device's ability to measure the refractive index as well as the width of thin transparent films to the smallest conceivable unit, such as 1nm. This factor has given ellipsometry a distinct position in the global market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The increasing frequency of outbreaks caused by infectious organisms such as Haemophilus influenzae, Streptococcus pneumoniae, Shigella, Vibrio cholera, Neisseria meningitides, Neisseria gonorrhoeae, and Salmonella serotype Typhi is driving up demand for antimicrobial susceptibility testing kits.
According to the World Health Organization, tuberculosis is one of the top ten causes of death and the main cause of a single infectious agent. In 2018, it was predicted that 10 million individuals worldwide were infected with tuberculosis, with 1.5 million dying as a result of the disease. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), 1.7 million people were newly infected with HIV in 2019, 38 million people are HIV-positive, and 690 thousand people died from AIDS-related illnesses in 2019. The World Malaria Report 2019 estimates that 228 million cases of malaria were diagnosed worldwide. According to the report, nineteen nations in Sub-Saharan Africa and India carried about 85 percent of the worldwide malaria load. All of these increasing instances will boost market demand.
Furthermore, the increased focus on drug discovery, the emergence of new diseases, the increasing incidences of chronic disorders, and the emergence of antimicrobial resistance (AMR) have increased biopharmaceutical, biotechnological, and pharmaceutical companies' use of antimicrobial susceptibility testing. During the projected period, this tendency is expected to boost the growth of the antimicrobial susceptibility testing market.
Automated antimicrobial susceptibility testing tools are expensive and have very advanced features and functionality. This affects the entire cost of therapy and makes it difficult for the patient party to pay the expenses.
At the same time, this approach is out of reach for modest healthcare institutions due to the large cash required to run this automated process. The adoption of automated antimicrobial susceptibility testing systems minimizes the time required for incubation and detection. However, the high cost of these systems is a key barrier to widespread adoption by end users, particularly small-budget institutions.
The time lag between establishing clinical thresholds, approval of new antimicrobial drugs, and inclusion of these medicines in antimicrobial susceptibility testing is one of the primary issues confronting the AST market. When medication manufacturers submit individual new drug applications or device manufacturers submit requests to change the breakpoints, the FDA establishes these breakpoints. Furthermore, the lack of clinical breakpoints for many medicines is limiting the use of AST products.
Principal Consultant
In 2021, North America held the greatest share of the AST market. The rising frequency of infectious diseases, safety concerns, and technological improvements in antimicrobial susceptibility products are the primary factors driving market growth in North America.
Furthermore, most of the world's leading firms, such as Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, and Bruker Corporation, are located or have a substantial presence in the region. Others have concentrated on growth in order to broaden their reach and skills. This is another important component contributing to the market's rapid rise.
The rapid availability of information on bacterial infections and their antibiotic susceptibility aids in the timely adoption of suitable treatment therapy, which plays a significant role in illness management. These factors have been a major driver of demand in the North American market.
According to the analysis, the major factors driving the APAC antimicrobial susceptibility testing market are an increase in the incidence of infectious diseases combined with epidemic and pandemic occurrences, an increase in the adoption of antimicrobial susceptibility testing, and the innovation of manual and automated products.
There are significant potential prospects for the antimicrobial susceptibility testing market in growing APAC countries due to improved healthcare infrastructure, an increase in neglected healthcare demands, and an increase in the prevalence of antibiotic resistance in populations. Furthermore, the availability of numerous manual and automated solutions that deliver results in less time with improved accuracy for testing is a growing potential for leading industry players in this area to engage in the antimicrobial susceptibility testing market, which would accelerate growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Beckman Coulter, Inc., ThermoFisher Scientific Inc., HiMedia Laboratories, Becton, Dickinson and Company, Creative Diagnostics, MERLIN, Alifax, Bioanalyse, bioMerieux are among the top players of antimicrobial susceptibility testers market.
| Report Attribute | Details |
|---|---|
| Growth Rate | 5.6% CAGR from 2022 to 2032 |
| Market Value in 2022 | USD 3.70 Billion |
| Market Value in 2032 | USD 6.37 Billion |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | USD Million for Value |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Equipment Type, Application, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; CIS & Russia; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM, Germany, Italy, UK, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe, Greater China, India, South Korea, ASEAN Countries, Rest of APEJ, GCC Countries, Turkey, Iran, Israel, S.Africa, Rest of MEA |
| Key Companies Profiled | Beckman Coulter, Inc.; ThermoFisher Scientific Inc.; HiMedia Laboratories; Becton; Dickinson and Company; Creative Diagnostics; MERLIN; Alifax; Bioanalyse; BioMerieux |
| Customization Scope | Available upon Request |
The global antimicrobial susceptibility tester market is expected to grow at a 5.6% CAGR and secure USD 6.37 Billion by 2032.
North America is expected to be the most lucrative market for antimicrobial susceptibility tester during the forecast period
Beckman Coulter, Inc., ThermoFisher Scientific Inc., HiMedia Laboratories, Becton, Dickinson and Company, Creative Diagnostics, MERLIN, Alifax, Bioanalyse, bioMerieux are some of the known players in the antimicrobial susceptibility tester market.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 5.1. Clinical Diagnosis 5.2. Drug Discovery 5.3. Others 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Equipment Type 6.1. Automatic Antimicrobial Susceptibility Testers 6.2. Manual Antimicrobial Susceptibility Testers 6.3. Custom Antimicrobial Susceptibility Testers 6.4. MIC Strips 6.5. Susceptibility Plates 6.6. Other Accessories 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. Asia Pacific 7.5. MEA 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13. Key Countries Market Analysis 14. Market Structure Analysis 15. Competition Analysis 15.1. Beckman Coulter, Inc. 15.2. ThermoFisher Scientific Inc. 15.3. HiMedia Laboratories 15.4. Becton, Dickinson and Company 15.5. Creative Diagnostics 15.6. MERLIN 15.7. Alifax 15.8. Bioanalyse 15.9. bioMerieux 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Testing Equipment Insights
View Reports
Antimicrobial Susceptibility Tester Market
